Skip to main content

Citius Pharmaceuticals, Inc.

CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506251

No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Citius Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CTXR: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders7574−1
Shares25.3M24.9M−398.2K (−1.6%)
Value$30.4M$17.1M−$13.3M (−43.8%)

New holders (10)

Institutions that held Citius Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CTXR in Q3 2023
InstitutionSharesValue% of portfolio
Wealth Advisory Solutions, LLC154,130$105.5K0.02%
Key Bridge Compliance, LLC154,130$105.5K0.03%
Allspring Global Investments Holdings, LLC111,428$76.3K0.00%
Arkadios Wealth Advisors100,000$68.4K0.01%
SG Americas Securities, LLC57,614$39.0K0.00%
XTX Topco Ltd29,077$19.9K0.00%
Simplex Trading, LLC27,063$18.0K0.00%
Group One Trading, L.P.25,602$17.5K0.00%
GTS Securities LLC10,068$6.89K0.00%
Measured Wealth Private Client Group, LLC10,000$6.84K0.00%

Sold out (11)

Institutions that held Citius Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CTXR in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Verition Fund Management LLC83,800$100.6K
Jane Street Group, LLC71,770$86.1K
MetLife Investment Management69,745$83.7K
Millennium Management LLC62,675$75.2K
Two Sigma Investments, LP39,031$46.8K
Perritt Capital Management Inc25,000$30.0K
Virtu Financial LLC23,846$29.0K
FNY Investment Advisers, LLC15,000$18.0K
Metropolitan Life Insurance Co7,227$8.67K
National Bank of Canada4,630$5.51K
Meitav Dash Investments Ltd13,040–